홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

4-Methylmorpholine → [1-(6-{5-[4-(6-{2-[4-Cyano-1-(2-methoxycarbonylamino-butyryl)-pyrrolidin-2-yl]-3H-imidazol-4-yl}-naphthalen-2-yl)-phenyl]-1H-imidazol-2-yl)-5-aza-spiro[2.4]heptane-5-carbonyl)-2-methyl-propyl]-carbamic acid methyl ester

HRID 79920
노트
인쇄 미리보기

반응식

HRID 79920 반응식
[CH3:1][O:2][C:3]([NH:5][CH:6]([CH2:10][CH3:11])[C:7](O)=[O:8])=[O:4].C1C=CC2N(O)N=NC=2C=1.Cl.Cl.Cl.[CH3:25][O:26][C:27](=[O:75])[NH:28][CH:29]([C:33]([N:35]1[CH:41]([C:42]2[NH:43][C:44]([C:47]3[CH:52]=[CH:51][C:50]([C:53]4[CH:62]=[CH:61][C:60]5[C:55](=[CH:56][CH:57]=[C:58]([C:63]6[NH:64][C:65]([CH:68]7[CH2:72][CH:71]([C:73]#[N:74])[CH2:70][NH:69]7)=[N:66][CH:67]=6)[CH:59]=5)[CH:54]=4)=[CH:49][CH:48]=3)=[CH:45][N:46]=2)[CH2:40][C:37]2([CH2:39][CH2:38]2)[CH2:36]1)=[O:34])[CH:30]([CH3:32])[CH3:31].CN1CCOCC1>CN(C=O)C.CCOC(C)=O>[CH3:25][O:26][C:27](=[O:75])[NH:28][CH:29]([C:33]([N:35]1[CH:41]([C:42]2[NH:43][C:44]([C:47]3[CH:48]=[CH:49][C:50]([C:53]4[CH:62]=[CH:61][C:60]5[C:55](=[CH:56][CH:57]=[C:58]([C:63]6[NH:64][C:65]([CH:68]7[CH2:72][CH:71]([C:73]#[N:74])[CH2:70][N:69]7[C:7](=[O:8])[CH:6]([NH:5][C:3]([O:2][CH3:1])=[O:4])[CH2:10][CH3:11])=[N:66][CH:67]=6)[CH:59]=5)[CH:54]=4)=[CH:51][CH:52]=3)=[CH:45][N:46]=2)[CH2:40][C:37]2([CH2:38][CH2:39]2)[CH2:36]1)=[O:34])[CH:30]([CH3:32])[CH3:31]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 79724-MethylmorpholineHCID 757711-HydroxybenzotriazoleHCID 434699742-Methoxycarbonylamino-butyric acidHCID 66620626(1-(6-[5-(4-{6-[2-(4-Cyano-pyrrolidin-2-yl)-3H-imidazol-4-yl]-naphthalen-2-yl}-phenyl)-1H-imidazol-2-yl]-5-aza-spiro[2.4]heptane-5-carbonyl)-2-methyl-propyl)-carbamic acid methyl ester-tris-hydrochloride

생성물 1

HCID 66621139
[1-(6-{5-[4-(6-{2-[4-Cyano-1-(2-methoxycarbonylamino-butyryl)-pyrrolidin-2-yl]-3H-imidazol-4-yl}-naphthalen-2-yl)-phenyl]-1H-imidazol-2-yl)-5-aza-spiro[2.4]heptane-5-carbonyl)-2-methyl-propyl]-carbamic acid methyl ester
수율 54.4%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 8857Ethyl Acetate용매

실험 절차

2-Methoxycarbonylamino-butyric acid (37 mg, 0.227 mmol) EDC-HCl (44 mg, 0.227 mmol) and HOBt (32 mg, 0.237 mmol) were combined in DMF (2 mL) and stirred for 20 min at RT. (1-{6-[5-(4-{6-[2-(4-Cyano-pyrrolidin-2-yl)-3H-imidazol-4-yl]-naphthalen-2-yl}-phenyl)-1H-imidazol-2-yl]-5-aza-spiro[2.4]heptane-5-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester-tris-hydrochloride (150 mg, 0.189 mg) was added, the reaction mixture was cooled to 0° C. and NMM (0.104 mL, 0.947 mmol) was added dropwise. After 1.5 h, the reaction mixture was warmed to RT. 30 min later, the mixture was diluted with EtOAc and washed with NaHCO3, then 1:1 brine/5M NaOH. The organic phase was dried over MgSO4, then filtered and concentrated. The resulting residue was purified by HPLC to afford the title compound (85 mg, 54%). MS (ESI) m/z 826 [M+H]+.

후처리

  1. temperaturethe reaction mixture was cooled to 0° C.
  2. waitAfter 1.5 h
  3. temperaturethe reaction mixture was warmed to RT
  4. washwashed with NaHCO3
  5. dry with materialThe organic phase was dried over MgSO4
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe resulting residue was purified by HPLC

출처 및 근거

ORD 기록
ord-ab712b99fae24d7ebe8677ad3387aa4b
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08841278B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트